Guy Wood-Gush

Guy Wood-Gush is an experienced healthcare investment and operations professional with a strong background in Digital Health, AI, Biotechnology, Pharmaceutical, Medical Device, and Medical Services industries.

He has a wealth of experience in finance, capital markets, venture capital, EIS, surgical practice, and research, with a focus on ESG principles.

Guy's expertise extends to start-up and venture finance, mergers and acquisitions, IPOs, capital markets, intellectual property, technology transfer/licensing, regulatory affairs, and NED roles.

His educational background includes studies at renowned institutions like Stanford University, INSEAD, King's College London School of Medicine, and The Edinburgh Academy.

Throughout his career, Guy has held key positions in notable organizations such as Queen Mary University, London, Manus Neurodynamica, Deontics Ltd, The Royal Society of Medicine, Cambridge Cognition Ltd, Cancer Research Ventures Ltd., Qugen Therapeutics, Biotech Research Ventures (Singapore), J.P. Morgan, BZW (Barclays de Zoete Wedd), and Eli Lilly and Company.